Zhejiang Huahai Stock Hits Day Low of CNY 15.28 Amid Price Pressure

Zhejiang Huahai Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 3.16% on March 3, 2026. The stock reached an intraday low of CNY 15.28, reflecting ongoing challenges within the company. Over the past week, the stock has decreased by 4.31%, contrasting with a slight gain of 0.41% in the China Shanghai Composite index. In terms of longer-term performance, Zhejiang Huahai has faced significant hurdles, with a year-to-date decline of 9.72% and a three-year drop of 24.05%. The company's financial metrics indicate a high debt-to-equity ratio of 0.70, which raises concerns about its financial stability. Additionally, the return on equity stands at 4.24%, suggesting limited profitability relative to shareholder funds. Despite a dividend yield of 1.59%, the company's net sales have fallen by 11.88%, and its operating profit has decreased by 13.17% over the past five years. These factors contribute to a challenging market position for Zhejiang Huahai Pharmaceutical, as it continues to underperform compared to broader market trends.